Dr. Yaodong Zhu | Dentistry | Best Researcher Award
Chief physician, The First Affiliated Hospital of Anhui Medical University, China
Zhu Yaodong (朱耀东), a renowned Chief Physician at The First Affiliated Hospital of Medical University of Anhui, specializes in integrative medicine with a focus on oncology. Born on March 11, 1984, in Ma’anshan City, Anhui Province, he earned his Bachelor’s and Ph.D. in Chinese and Western integrative medicine. With over 16 years of clinical and research experience, Dr. Zhu has published extensively on topics like gastric cancer, tumor immunity, and Helicobacter pylori infections. His contributions to combining traditional Chinese medicine (TCM) and modern oncology make him a pioneer in his field.
Publication Profile
Education
Bachelor’s (2003–2008): Anhui University of Traditional Chinese Medicine, major in Chinese and Western integrative medicine. Ph.D. (2010–2015): Yangzhou University, major in Chinese and Western integrative medicine (Oncology), focusing on clinical and basic malignant tumor research in TCM.
Experience 
2008–2010: Resident Doctor, TCM Hospital, Ma’anshan, Anhui Province. 2015–2017: Attending Doctor, Anhui Provincial Hospital, Hefei. 2017–2024: Attending Doctor, The First Affiliated Hospital of Medical University of Anhui. 2024–Present: Chief Physician, The First Affiliated Hospital of Medical University of Anhui.
Awards and Honors 
Numerous SCI publications in leading oncology journals. Recognition for groundbreaking work integrating TCM with oncology. Leading research contributions on gastric cancer treatment and Helicobacter pylori infection mechanisms.
Research Focus 
Integrative Medicine: Combining traditional Chinese medicine (TCM) with Western oncology practices. Cancer Research: Mechanisms of Helicobacter pylori in gastric cancer and innovative treatments using TCM. Drug Development: Exploration of Celastrus orbiculatus extracts for anti-cancer properties. Systematic Reviews: Analysis of cancer therapies’ efficacy and tolerability.
Conclusion
Dr. Zhu Yaodong is a highly qualified candidate for the Best Researcher Award due to his strong academic background, extensive research contributions, and innovative integration of traditional and modern medical practices. Addressing broader research diversity and leadership roles could further elevate his profile. His work stands out for its potential to transform integrative oncology, making him a strong contender for the award.
Publication Top Notes
- Celastrus orbiculatus Thunb. extract inhibits inflammatory metabolic adaptation in macrophages and regulates polarization via modulating PKM2
- Authors: Zhang X., Wen J., Pan Z., Liu Y., Zhu Y.
- Journal: International Immunopharmacology
- Year: 2025
- Volume: 144, Article: 113665
- Mechanism of Reversal of Precancerous Lesions of Gastric Cancer by Celastrus orbiculatus Extract via Regulating Lgr5/Wnt/β-catenin Signaling Pathway
- Authors: Zhang X., Zhu F., Wen J., Liu Y., Zhu Y.
- Journal: Chinese Journal of Experimental Traditional Medical Formulae
- Year: 2024
- Volume: 30(12), Pages: 70–77
- Celastrus orbiculatus extract reverses precancerous lesions of gastric cancer by inhibiting autophagy via regulating the PDCD4-ATG5 signaling pathway
- Authors: Zhu F., Zhang X., Wen J., Liu Y., Zhu Y.
- Journal: Journal of Pharmacy and Pharmacology
- Year: 2024
- Volume: 76(3), Pages: 257–268
- Citations: 4
- Celastrus orbiculatus Extract Reduces Stemness of Gastric Cancer Stem Cells by Targeting PDCD4 and EIF3H
- Authors: Zhu Y.-D., Ba H., Chen J., Zhang M., Li P.
- Journal: Integrative Cancer Therapies
- Year: 2021
- Volume: 20
- Citations: 12
- Correlation Between FOXOs Genes Expression and Helicobacter Pylori Infection in Gastric Cancer and Its Clinical Significance
- Authors: Wen J., Zhang X., Peng Q., Liu B., Zhu Y.
- Journal: Cancer Research on Prevention and Treatment
- Year: 2024
- Volume: 51(10), Pages: 840–846
- Helicobacter pylori infection and PD-L1 expression in gastric cancer: A meta-analysis
- Authors: Zhu Y., Zhu F., Ba H., Chen J., Bian X.
- Journal: European Journal of Clinical Investigation
- Year: 2023
- Volume: 53(2), Article: e13880
- Citations: 7
- Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta-analysis
- Authors: Zhu F., Zhang X., Li P., Zhu Y.
- Journal: Helicobacter
- Year: 2023
- Volume: 28(6), Article: e13013
- Citations: 9
- Comparison of efficacy and tolerability of adjuvant therapy for resected high-risk stage III-IV cutaneous melanoma: a systemic review and Bayesian network meta-analysis
- Authors: Ba H., Zhu F., Zhang X., Mei Z., Zhu Y.
- Journal: Therapeutic Advances in Medical Oncology
- Year: 2023
- Volume: 15
- Citations: 5
- The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
- Authors: Ba H., Liu L., Peng Q., Chen J., Zhu Y.-D.
- Journal: BMC Cancer
- Year: 2021
- Volume: 21(1), Article: 1220
- Citations: 10